SECOND SUPPLEMENTAL APPROPRIATION BILL FOR 1951 HEARINGS BEFORE SUBCOMMITTEES OF THE EIGHTY-FIRST CONGRESS SECOND SESSION ON SECOND SUPPLEMENTAL CARD D COMMERCE DEPARTMENT JUSTICE DEPARTMENT LABOR-FEDERAL SECURITY STATE DEPARTMENT Printed for the use of the Committee on Appropriations 51-60105 SECOND SUPPLEMENTAL APPROPRIATION BILL FOR 1951 Y.S. Congress SUBCOMMITTEES OF THE COMMITTEE ON APPROPRIATIONS EIGHTY-FIRST CONGRESS SECOND SESSION COMMITTEE ON APPROPRIATIONS CLARENCE CANNON, Missouri, Chairman JOHN H. KERR, North Carolina LOUIS C. RABAUT, Michigan DANIEL J. FLOOD, Pennsylvania CHRISTOPHER C. MCGRATH, New York SIDNEY R. YATES, Illinois FOSTER FURCOLO, Massachusetts JOHN TABER, New York RICHARD B. WIGGLESWORTH, Massachusetts FRANCIS CASE, South Dakota H. CARL ANDERSEN, Minnesota NORRIS COTTON, New Hampshire JOHN E. FOGARTY, Rhode Island, Chairman E. H. HEDRICK, West Virginia New York 1 Temporarily assigned. FRANK B. KEEFE, Wisconsin 1 TUESDAY, DECEMBER 5, 1950. FEDERAL SECURITY AGENCY PUBLIC HEALTH SERVICE WITNESSES DR. LEONARD SCHEELE, SURGEON GENERAL DR. NORMAN TOPPING, ASSOCIATE DIRECTOR, NATIONAL INSTITUTES OF HEALTH DR. JOHN CRONIN, MEDICAL DIRECTOR, HOSPITAL FACILITIES DIVISION PROGRAMS OF RESEARCH CONTEMPLATED AND NEEDED UNDER PUBLIC LAW 692 Mr. FOGARTY. The committee will come to order. The committee has before it this afternoon Dr. Scheele of the Public Health Service, and some of his assistants. There are some questions in my mind, Doctor, as to the necessity of an appropriation for the Arthritis and Rheumatism Institute and the Institute for Blindness and Neurological Diseases that Congress authorized by law this year. As I recall, you appeared before the Senate committee in the fall. This committee held no hearing on funds for that law. The budget request to the Senate was for $3,000,000 for the remainder of fiscal 1951, and that was allowed, but in conference was taken out. I thought in a few minutes this afternoon you might give us a résumé of your testimony before the Senate, and say something as to the necessity of starting these institutes as of this fiscal year. Would you want to start and tell us something, Doctor, first about the Arthritis and Rheumatism Institute and the history of it, what has been accomplished up to now, and where we stand at the present time? Dr. SCHEELE. Yes, sir, Mr. Chairman. Members of the committee: On August 15 there was signed into law the so-called omnibus research institute bill, which provided the structure of the National Institutes of (1) |